Plain-English translation of NCT07042529 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a more careful way of expanding a replacement aortic valve — called the OptEx technique — can reduce valve thickening after a minimally invasive heart valve replacement procedure. The study will compare two groups: one that receives the standard care approach and one that receives the new optimized expansion technique. Both groups will have the same type of valve replacement procedure, just with different methods of expanding the valve.
After a transcatheter aortic valve implantation (a catheter-based heart valve replacement), some patients develop thickening of the valve leaflets, which can affect how well the valve works over time. Researchers believe that using a more careful and systematic way to expand the replacement valve during the procedure might reduce this thickening and improve long-term outcomes.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the standard valve expansion approach or the optimized expansion technique during your heart valve replacement procedure. After the procedure, you will visit the clinic at discharge (with an ultrasound of your heart), again at 3 months and 1 year (with ultrasound and heart imaging), and at 5 years (with advanced imaging). Each visit takes place at the hospital on-site, and the study lasts up to 5 years.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
Belgium
Denmark